Braeburn

Braeburn (operating at braeburnrx.com) is a pharmaceutical company engineered for delivering solutions for people living with the serious consequences of opioid use disorder. Founded in 2012 and headquartered in Plymouth Meeting, Pennsylvania, Braeburn transforms the management of OUD to help people begin and sustain recovery. Under the hood, Braeburn manufactures, markets, and/or distributes drugs in the U.S. This allows patients to access treatment and improve their quality of life. Backed by a $110 million mezzanine round of financing led by Wellington Management Company.